Hepatoid Gland Tumors in Dogs: Symptoms and Treatment

Understanding Hepatoid Gland Tumors in Dogs

Hepatoid gland tumors, also known as perianal gland tumors, are among the most common skin tumors found in dogs, accounting for approximately 25% of all cutaneous epithelial tumors in canines. These tumors develop from modified sebaceous glands located in the perianal area, as well as other regions including the tail base, vulva, prepuce, caudal dorsum, and hind legs. The term “hepatoid” refers to the similarity in cell morphology to hepatocytes (liver cells), which is why these tumors share their distinctive name. Understanding these tumors is crucial for dog owners, as early detection and treatment can significantly improve outcomes for affected pets.

What Are Hepatoid Glands?

Hepatoid glands are specialized sebaceous glands of the skin located primarily in the perianal region of dogs. These glands contain receptors for androgen, estrogen, and growth hormones, making them responsive to hormonal changes in the body. The glands are found in various locations including around the anus, at the tail base, near the vulva, in the prepuce area, along the caudal dorsum, and on the hind legs. The cellular structure of hepatoid glands closely resembles liver cells, which is how they earned their distinctive name. This hormonal sensitivity plays a significant role in tumor development, particularly in intact (non-neutered) males.

Types of Hepatoid Gland Tumors

Hepatoid gland neoplasms are classified into three main categories based on their characteristics and behavior:

Benign Tumors (Adenomas)

Hepatoid gland adenomas (HGAs) represent approximately 60% of all perianal tumors and account for the majority of hepatoid gland neoplasms in dogs. These benign tumors are typically slow-growing and well-circumscribed lesions. They are most commonly found in intact male dogs, with studies showing that benign hepatoid gland tumors occur primarily in males that have not been neutered. The prognosis for benign hepatoid tumors is generally favorable, and castration combined with marginal surgical excision is often curative with very low local recurrence rates.

Epitheliomas

Epitheliomas represent an intermediate category of hepatoid gland tumors, showing characteristics between benign adenomas and malignant carcinomas. These tumors may display variable growth patterns and require careful histopathological examination to determine their exact nature and potential for progression.

Malignant Tumors (Carcinomas)

Hepatoid gland carcinomas (HGCs) account for a smaller percentage of perianal tumors but represent the most aggressive form of hepatoid gland neoplasia. These malignant tumors are characterized by rapid growth and increased potential for metastasis. Malignant tumors are associated with various aggressive features including skin ulceration, tissue necrosis, invasion of surrounding tissues, and lymphatic metastasis.

Risk Factors and Prevalence

Several factors influence the development of hepatoid gland tumors in dogs. Male dogs are significantly more affected than females, with tumors occurring in males three times more often than in females. Intact (non-neutered) males have a particularly high risk, as most hepatoid gland adenomas develop in dogs that have not been castrated. Age is another important factor, with these tumors being most common in older dogs.

Certain dog breeds show increased susceptibility to hepatoid gland tumors. Siberian Huskies, Samoyeds, Pekingese, and Cocker Spaniels are among the breeds most commonly affected. This breed predisposition suggests a genetic component to tumor development, though the exact mechanisms are not completely understood.

Clinical Presentation and Symptoms

Hepatoid gland tumors typically present as single or multiple masses located in specific areas of the body. Common locations include the perianal region, tail, hind limbs, parapreputial area, and vulva. The tumors usually appear as:

• Pink, hairless lesions
• Slow-growing masses (in benign cases)
• Well-circumscribed lesions with an average diameter between 0.5 and 3 cm
• Compressible nodules

In some cases, hepatoid gland tumors may induce an inflammatory response or surface ulceration. Dogs may exhibit signs of discomfort or licking at the affected area. Malignant tumors tend to grow more rapidly and may show signs of ulceration, bleeding, or discharge. In advanced cases, affected dogs may experience pain, difficulty sitting or defecating, or other signs related to the tumor’s location and size.

Diagnosis and Evaluation

Proper diagnosis of hepatoid gland tumors requires a comprehensive approach combining clinical examination with definitive histopathological diagnosis. Early detection is essential for optimal treatment selection and prognosis determination. The diagnostic process typically includes:

Physical Examination

The veterinarian will perform a thorough physical examination of the affected area, noting the location, size, appearance, and characteristics of any masses. The presence of ulceration, inflammation, or discharge will be documented.

Biopsy and Histopathology

A tissue biopsy is essential for definitive diagnosis. Samples are examined microscopically to determine the tumor type (adenoma, epithelioma, or carcinoma) and grade. Histopathological evaluation assesses various parameters that correlate with prognosis, including anisocytosis, anisokaryosis, mitotic count, presence of tumor-infiltrating lymphocytes, sebaceous differentiation, capsule presence, calcifications, infiltrative growth patterns, ductal differentiation, and ulceration.

Staging and Metastasis Detection

For malignant tumors, additional diagnostic imaging may be recommended to assess regional lymph nodes and detect potential metastases. The TNM (Tumor, Node, Metastasis) staging system is used to classify the disease stage, which helps determine prognosis and treatment recommendations.

Factors Associated with Malignancy

Tumor size plays a crucial role in predicting malignancy and prognosis. Dogs with small tumors (less than 3 cm) were clinically speculated as benign in 70.6% of cases, while those with medium tumors (3–5 cm) showed 41.7% low-grade malignancy. In contrast, dogs with large tumors (greater than 5 cm) were diagnosed as hepatoid gland carcinomas in 90% of cases. Additionally, dogs with large tumor size had 4.5 and 11 times higher risk of recurrence and tumor-related mortality, respectively.

Malignant hepatoid gland carcinomas are associated with several aggressive features including skin ulceration (66.7%), tissue necrosis (80%), invasion of surrounding tissues (66.7%), and lymphatic metastasis (46.7%). Histological grade significantly affects patient outcomes, with high-grade tumors showing substantially worse disease-free intervals and overall survival rates compared to low-grade tumors.

Treatment Options

Treatment decisions depend on whether the tumor is benign or malignant, as well as the overall health status of the dog. The primary treatment modalities include:

Surgical Excision

Surgical removal is the most common and often most effective treatment for hepatoid gland tumors. For benign adenomas, marginal surgical excision is typically curative with very low local recurrence rates. Castration combined with surgical excision offers excellent results for intact males with benign tumors. Complete surgical resection with appropriate excision margins is important, as incomplete surgical resection may be a risk factor for recurrence.

Hormonal Therapy

Benign hepatoid gland tumors have significantly high androgen expression and low estrogen expression. These tumors have been known to regress following castration in intact males or following estrogen therapy. Castration is often recommended as part of the treatment protocol, even for neutered males, as it may help prevent future tumor development.

Chemotherapy

For malignant hepatoid gland carcinomas or cases where surgical excision is not feasible, chemotherapy may be considered. This treatment is typically reserved for more aggressive cases or those with evidence of metastatic disease.

Prognosis and Outcome

The prognosis for hepatoid gland tumors varies significantly based on tumor type and characteristics. For benign hepatoid adenomas, the prognosis is generally favorable, with castration and marginal surgical excision being curative in most cases. However, local regrowth after surgery in a neutered male is suggestive of tumor malignancy.

For malignant hepatoid gland carcinomas, prognosis depends on clinical stage and various prognostic factors. Dogs bearing tumors larger than 5 cm in diameter have an 11-fold higher risk of death. Dogs with stage 1 and stage 2 tumors had a disease-free interval of 2 years, while a 1-year survival rate of 75% was recorded in dogs with T1 tumors and 60% in dogs with T2 tumors. Histological grade significantly influences outcomes, with dogs bearing low-grade hepatoid gland tumors demonstrating substantially better disease-free intervals and overall survival rates compared to those with high-grade tumors.

Prevention and Management

While hepatoid gland tumors cannot be completely prevented, certain management strategies may reduce risk:

• Castration of intact male dogs significantly reduces the incidence of benign hepatoid gland adenomas
• Regular monitoring of high-risk breeds, particularly Siberian Huskies, Samoyeds, Pekingese, and Cocker Spaniels
• Prompt veterinary evaluation of any unusual masses or lesions in the perianal region or other susceptible areas
• Early detection and treatment, which substantially improve outcomes and quality of life

Frequently Asked Questions

Q: Are hepatoid gland tumors cancerous?

A: Hepatoid gland tumors can be either benign or malignant. Approximately 60% are benign adenomas, while the remainder may be more aggressive carcinomas. Proper histopathological diagnosis is essential to determine the tumor type and appropriate treatment.

Q: Can hepatoid gland tumors be cured?

A: Yes, benign hepatoid gland adenomas can typically be cured through surgical excision, often combined with castration in intact males. Malignant tumors have variable outcomes depending on stage and grade, but early detection and treatment significantly improve prognosis.

Q: Will castration prevent hepatoid gland tumors?

A: Castration significantly reduces the incidence of benign hepatoid gland adenomas, particularly in intact males. However, it cannot completely prevent malignant tumors, which can develop in neutered animals.

Q: What is the survival rate for dogs with hepatoid gland carcinoma?

A: Survival rates depend on tumor stage and grade. Dogs with stage 1 tumors typically have 2-year disease-free intervals, while those with T1 tumors have approximately 75% 1-year survival rates. Dogs with high-grade tumors have substantially lower survival rates.

Q: Are certain dog breeds more prone to hepatoid gland tumors?

A: Yes, Siberian Huskies, Samoyeds, Pekingese, and Cocker Spaniels are among the breeds most commonly affected by hepatoid gland tumors. Owners of these breeds should be particularly vigilant in monitoring their dogs.

Q: What should I do if I notice a lump near my dog’s anus?

A: Any unusual lumps or masses should be evaluated by a veterinarian as soon as possible. Early diagnosis and treatment can significantly improve outcomes, so prompt veterinary attention is essential.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete